Medication Prescribing Patterns at a Youth Mental Health Service: A Single Center Retrospective Cross-sectional Study
Journal of Child and Adolescent Psychopharmacology · 2025
DOI: 10.1089/cap.2024.0140 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Journal of Child and Adolescent Psychopharmacology, 2025. Verfasst von Angela Dinh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health, The University of Sydney School of Pharmacy, The University of Sydney, Camperdown, New South Wales, Australia. Hauptthemen laut MEDLINE: Mental Disorders, Practice Patterns, Physicians', Mental Health Services, Drug Prescriptions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
Objective
Rates of mental illness among young people remain elevated, and the utilization of youth mental health services is expected to increase. Yet, there is limited knowledge on real-world medication usage and prescribing at these services. Hence, the aim of this study was to explore the medication prescribing patterns at a headspace center, an Australian youth mental health service.
Methods
A retrospective cross-sectional study of medical records was conducted. Demographic data, clinical information, prescribed medications, and reasons for use of young people who attended an intake assessment at headspace Camperdown over a 13-month period, February 2021-February 2022, were analyzed. Data collection focused on medication molecule, strength, dose, prescriber designation, and indication. Data were analyzed descriptively.
Results
Records for 608 participants were included. The median age at intake was 19.9 years old (interquartile range: 16.1-22.4), and most participants identified as female (n = 372, 61.2%). Anxiety (n = 246, 40.5%) and low mood (n = 95, 15.6%) were the most common presenting concerns. Almost half of participants (n = 291, 47.9%) reported using medication/s at intake, and almost one in five participants (n = 119, 19.6%) were prescribed a medication at the service. The most prescribed medications at headspace were melatonin (24.0%) and quetiapine (12.3%), as well as the antidepressants escitalopram (15.1%), sertraline (11.2%), and fluoxetine (7.3%).
Conclusions
This study provides insights into the prescribing practices at a single headspace center. Further investigations are needed to explore the impacts of off-label prescribing for young people, particularly in relation to melatonin and quetiapine, where safety and efficacy in young people have not been well established.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine and Health, The University of Sydney School of Pharmacy, The University of Sydney, Camperdown, New South Wales, Australia.
- Brain and Mind Centre, The University of Sydney, Camperdown, New South Wales, Australia.
- headspace Camperdown, Brain and Mind Centre, The University of Sydney, Camperdown, New South Wales, Australia.
ORCID-Profile: Claire L O'Reilly
Zitieren
APA
Dinh, A., El-Den, S., Collins, J. C., Hamilton, B., Janiszewski, C. M. S., Fowler, D., & O'Reilly, C. L. (2025). Medication Prescribing Patterns at a Youth Mental Health Service: A Single Center Retrospective Cross-sectional Study. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/cap.2024.0140
Vancouver
Dinh A, El-Den S, Collins JC, Hamilton B, Janiszewski CMS, Fowler D, et al. Medication Prescribing Patterns at a Youth Mental Health Service: A Single Center Retrospective Cross-sectional Study. Journal of Child and Adolescent Psychopharmacology. 2025. doi:10.1089/cap.2024.0140
BibTeX
@article{Dinh2025,
author = {Dinh, Angela and El-Den, Sarira and Collins, Jack C and Hamilton, Blake and Janiszewski, Connie M S and Fowler, Donna and O'Reilly, Claire L},
title = {Medication Prescribing Patterns at a Youth Mental Health Service: A Single Center Retrospective Cross-sectional Study},
journal = {Journal of Child and Adolescent Psychopharmacology},
year = {2025},
doi = {10.1089/cap.2024.0140}
}
EUVIMED